"Improving the outcomes and standards of care in cancerous and benign conditions with minimally invasive focused heat technologies."

Our treatment is designed with patients' needs and comfort in mind.

Who We Are

Medifocus, Inc. (TSXV-MFS, OTC-MDFZF) develops and commercializes minimally invasive treatment systems used in treatment of cancerous and benign tumors, and enlarged prostate, medically known as Benign Prostatic Hyperplasia (“BPH”).  The Company owns two technology platforms with approximately 100 issued and pending US and international patents:

ReadMore

The Prolieve® System

Our Prolieve Thermodilatation System was originally developed and commercialized by the current Medifocus management, product development, clinical and regulatory teams. In June 2012, Medifocus reached an agreement with Boston Scientific for the purchase of all of the assets of its Prolieve business,including all Prolieve inventory, the Rocky Mountain Mobile 

ReadMore

News Releases & Events

News Releases & Events 2018

• 12/03 MEDIFOCUS, INC. ANNOUNCES FDA PMA SUPPLEMENT APPROVAL FOR NEW LABELING BASED ON SUCCESSFUL COMPLETION OF FDA POST APPROVAL STUDY (PAS) FOR THE PROLIEVE® THERMODILATATION™ DEVICE

• 11/29 Medifocus, Inc. Submits For New Patent Titled “Thermodilatation and Thermocompression to Facilitate Targeted Cluster Tissue Ablation and Immune Response”

• 11/27 Medifocus, Inc. Announces 26% Increase in Revenue in Recent Quarter and Positive Cash Flow from Operation for the Six Months Ended Sept 30, 2018

• 06/05 Medifocus, Inc. Announces Successful Completion of FDA Post Approval Study (PAS) for the Prolieve® Thermodilatation™ System

• 01/09 Medifocus, Inc. Expands its Reach into the Israeli Market with Amos Gazit Ltd for Its Prolieve® Thermodilatation for BPH Therapy and Announces Significant Debt Conversion into Shares

News Releases & Events 2017

• 08/28 Medifocus, Inc. Announces Significant Improvement in Operating Results for the Fiscal Year Ended March 31, 2017 with Successful Expansion of Prolieve® Global Market & Launching of Prolieve® Prostatitis Study

• 03/16 Medifocus, Inc. Announces First Ever Quarterly Operating Profit and Significant Improvement in Operating Results for the Nine Months Ended December 31, 2016

News Releases & Events 2016

• 10/03 Medifocus Inc. Announces Appointment of New Chief Executive Officer

• 09/14 Medifocus Inc. Announces Election of Directors and Financial Results for the Quarter Ended June 30 2016

ReadMore